182 related articles for article (PubMed ID: 19809306)
1. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction.
Van Dreden P; Rousseau A; Savoure A; Lenormand B; Fontaine S; Vasse M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):635-41. PubMed ID: 19809306
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia?
Rousseau A; Favier R; Van Dreden P
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):46-9. PubMed ID: 19564071
[TBL] [Abstract][Full Text] [Related]
5. Plasma thrombomodulin, fibrinogen, and activity of tissue factor as risk factors for acute cerebral infarction.
Zhang X; Hu Y; Hong M; Guo T; Wei W; Song S
Am J Clin Pathol; 2007 Aug; 128(2):287-92. PubMed ID: 17638664
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction.
Andreotti F; Hackett DR; Haider AW; Roncaglioni MC; Davies GJ; Beacham JL; Kluft C; Maseri A
Thromb Haemost; 1992 Dec; 68(6):678-82. PubMed ID: 1287882
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
8. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
9. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
Figueras J; Monasterio J; Lidón RM; Sambola A; Garcia-Dorado D
Thromb Res; 2012 Sep; 130(3):458-62. PubMed ID: 22424853
[TBL] [Abstract][Full Text] [Related]
10. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
11. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
12. Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients.
Rigla M; Mateo J; Fontcuberta J; Souto JC; de Leiva A; Pérez A
Thromb Haemost; 2000 Aug; 84(2):223-7. PubMed ID: 10959693
[TBL] [Abstract][Full Text] [Related]
13. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
Bellucci S; Ignatova E; Jaillet N; Boffa MC
Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
[TBL] [Abstract][Full Text] [Related]
14. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
15. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
16. [Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].
Fernández Abellán P; Marín Ortuño F; Marco Vera P; Luján Martínez J
Rev Clin Esp; 1999 Apr; 199(4):215-7. PubMed ID: 10364793
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia.
Schneider P; Van Dreden P; Rousseau A; Kassim Y; Legrand E; Vannier JP; Vasse M
Br J Haematol; 2010 Feb; 148(4):582-92. PubMed ID: 19874310
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: the cause of hypercoagulability?
Van Dreden P; Woodhams B; Rousseau A; Favier M; Favier R
Thromb Res; 2012 Jun; 129(6):787-92. PubMed ID: 21880353
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.
Al-Nozha MM; Abdel-Gader AG; Arafah MR; Al-Maatouq MA; Al-Shahid MS; Al-Harthi SS; Khan NB; Abdullah MA
Saudi Med J; 2005 Jun; 26(6):937-42. PubMed ID: 15983678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
